Teva Pharmaceutical (Germany) Top Insiders

TEV Stock  EUR 20.30  0.40  1.93%   
Teva Pharmaceutical employs about 34 K people. The company is managed by 10 executives with a total tenure of roughly 79343 years, averaging almost 7934.0 years of service per executive, having 3400.4 employees per reported executive. Examination of Teva Pharmaceutical's management performance can provide insight into the company performance.
Eli Shani  Insider
Ex Portfolio
David Stark  Insider
Ex Officer
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teva Pharmaceutical Industries. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Teva Pharmaceutical Management Team Effectiveness

The company has return on total asset (ROA) of 0.0363 % which means that it generated a profit of $0.0363 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2414) %, meaning that it generated substantial loss on money invested by shareholders. Teva Pharmaceutical's management efficiency ratios could be used to measure how well Teva Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.

Teva Pharmaceutical Workforce Comparison

Teva Pharmaceutical Industries is currently regarded as top stock in number of employees category among its peers. The total workforce of Drug Manufacturers - Specialty & Generic industry is at this time estimated at about 46,571. Teva Pharmaceutical totals roughly 34,004 in number of employees claiming about 73% of equities under Drug Manufacturers - Specialty & Generic industry.
The company has Profit Margin (PM) of (0.16) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.18 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.18.

Teva Pharmaceutical Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Teva Pharmaceutical Price Series Summation is a cross summation of Teva Pharmaceutical price series and its benchmark/peer.

Teva Pharmaceutical Notable Stakeholders

A Teva Pharmaceutical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Teva Pharmaceutical often face trade-offs trying to please all of them. Teva Pharmaceutical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Teva Pharmaceutical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About Teva Pharmaceutical Management Performance

The success or failure of an entity such as Teva Pharmaceutical often depends on how effective the management is. Teva Pharmaceutical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Teva management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Teva management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel. TEVA PHARMACEUT operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 42535 people.

Teva Pharmaceutical Workforce Analysis

Traditionally, organizations such as Teva Pharmaceutical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Teva Pharmaceutical within its industry.

Teva Pharmaceutical Manpower Efficiency

Return on Teva Pharmaceutical Manpower

Revenue Per Employee438.9K
Revenue Per Executive1.5B
Net Loss Per Employee69.2K
Net Loss Per Executive235.3M

Complementary Tools for Teva Stock analysis

When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Fundamental Analysis
View fundamental data based on most recent published financial statements